$XBIT Balance Sheet | Understand Stock

$XBIT

$1.85 +$0.00 (0.0%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current assets:
Cash and cash equivalents
Interest bearing time deposit
Escrow receivable
Deferred cost of goods sold
Accrued interest receivable
Income tax receivable
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Deferred tax assets
Total assets

Current liabilities:
Accounts payable
Accrued expenses
Income tax payable
Convertible loan
Related Party
Nonrelated Party
Total convertible loan
Total current liabilities
Long-term liabilities:
Income tax payable
Deferred tax liability
Total liabilities
Shareholders’ equity:
Preferred stock, no par value, unlimited shares authorized, no shares outstanding
Common stock, no par value, unlimited shares authorized, 30,487,731 shares issued and outstanding at June 30, 2026 and December 31, 2025
Accumulated other comprehensive income
Accumulated deficit
Total shareholders’ equity
Total liabilities and shareholders’ equity

Comments